(3R*,4S*)-N-[3,5-bis(trifluoromethyl)benzyl]-N-methyl-3-phenylpiperidine-4-carboxamide hydrochloride

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (3R*,4S*)-N-[3,5-bis(trifluoromethyl)benzyl]-N-methyl-3-phenylpiperidine-4-carboxamide hydrochloride
• 英文别名: (3R*,4S*)-N-[3,5-bis(trifluoromethyl)benzyl]-N-methyl-3-phenylpiperidine-4-carboxamide monohydrochloride；(3R,4S)-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-N-methyl-3-phenylpiperidine-4-carboxamide;hydrochloride
• 化学式: C₂₂H₂₂F₆N₂O*ClH
• 分子量: 480.881
• InChiKey: AVESYTGPPLSEGU-HLRBRJAUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  32
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  (3R*,4S*)-N-[3,5-bis(trifluoromethyl)benzyl]-N-methyl-3-phenylpiperidine-4-carboxamide hydrochloride 、 异氰酸甲酯 在 三乙胺 、 柠檬酸 作用下， 以 乙腈 、 水 、 乙酸乙酯 为溶剂， 反应 14.0h， 以88%的产率得到(3R*,4S*)-N4-[3,5-bis(trifluoromethyl)benzyl]-N1,N4-dimethyl-3-phenylpiperidine-1,4-dicarboxamide
  参考文献：
  名称：

  EP1705176

  摘要：

  公开号：
• 作为产物：
  描述：

  tert-butyl (3R*,4S*)-4-[[[3,5-bis(trifluoromethyl)benzyl](methyl)amino]carbonyl]-3-phenylpiperidine-1-carboxylate 在 盐酸 作用下， 以 乙酸乙酯 为溶剂， 反应 2.0h， 以90%的产率得到(3R*,4S*)-N-[3,5-bis(trifluoromethyl)benzyl]-N-methyl-3-phenylpiperidine-4-carboxamide hydrochloride
  参考文献：
  名称：

  EP1705176

  摘要：

  公开号：

文献信息

• Piperidine derivative and use thereof
  申请人：Shirai Junya

  公开号：US20080275085A1

  公开（公告）日：2008-11-06

  The present invention provides a novel piperidine derivative and a tachykinin receptor antagonist containing same, as well as a compound represented by the formula: wherein R 1 is carbamoylmethyl, methylsulfonylethylcarbonyl and the like; R 2 is methyl or cyclopropyl; R 3 is a hydrogen atom or methyl; R 4 is a chlorine atom or trifluoromethyl; R 5 is a chlorine atom or trifluoromethyl; and a group represented by the formula: is a group represented by the formula: wherein R 6 is a hydrogen atom, methyl, ethyl or isopropyl; R 7 is a hydrogen atom, methyl or a chlorine atom; and R 8 is a hydrogen atom, a fluorine atom, a chlorine atom or methyl; or 3-methylthiophen-2-yl, and a salt thereof.

  本发明提供了一种新颖的哌啶衍生物和含有该衍生物的催吐肽受体拮抗剂，以及由下式表示的化合物： 其中R1为羰胺甲基、甲磺酰乙基羰基等；R2为甲基或环丙基；R3为氢原子或甲基；R4为氯原子或三氟甲基；R5为氯原子或三氟甲基；以及由下式表示的基团： 是由下式表示的基团： 其中R6为氢原子、甲基、乙基或异丙基；R7为氢原子、甲基或氯原子；R8为氢原子、氟原子、氯原子或甲基；或3-甲基噻吩-2-基，并且其盐。
• Carboxamide derivative and use thereof
  申请人：Ikeura Yoshinori

  公开号：US20090186874A1

  公开（公告）日：2009-07-23

  The present invention relates to a compound represented by the formula wherein ring A is a nitrogen-containing heterocycle optionally further having substituent(s), ring B and ring C are each an aromatic ring optionally having substituent(s), R 1 is a hydrogen atom, a hydrocarbon group optionally having substituent(s), an acyl group or a heterocyclic group optionally having substituent(s), Z is an optionally halogenated C 1-6 alkyl group, Y is a methylene group optionally having substituent(s), m and n are each an integer of 0 to 5, m+n is an integer of 2 to 5, and is a single bond or a double bond, or a salt thereof. The compound of the present invention has a superior tachykinin receptor antagonistic action, particularly an SP receptor antagonistic action, and is useful as a pharmaceutical agent, for example, a tachykinin receptor antagonist, an agent for the prophylaxis or treatment of an abnormality of lower urinary tract functions, a digestive organ disease or a central nerve disease, and the like.

  本发明涉及一种化合物，其表示为以下式子： 其中，环A是一种含氮杂环，可以选择进一步具有取代基；环B和环C分别是芳香环，可以选择进一步具有取代基；R1是氢原子，一个碳氢基团，可以选择进一步具有取代基，一个酰基基团或一个杂环基团，可以选择进一步具有取代基；Z是一个可选择卤代的C1-6烷基基团，Y是一个可选择具有取代基的亚甲基基团，m和n均为0到5的整数，m+n是2到5的整数，且是单键或双键，或其盐。本发明的化合物具有优异的速激肽受体拮抗作用，特别是SP受体拮抗作用，并且可用作制药剂，例如速激肽受体拮抗剂，预防或治疗下尿路功能异常、消化器官疾病或中枢神经疾病等。
• CARBOXAMIDE DERIVATIVE AND USE THEREOF
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1705176A1

  公开（公告）日：2006-09-27

  The present invention relates to a compound represented by the formula wherein ring A is a nitrogen-containing heterocycle optionally further having substituent(s), ring B and ring C are each an aromatic ring optionally having substituent(s), R1 is a hydrogen atom, a hydrocarbon group optionally having substituent(s), an acyl group or a heterocyclic group optionally having substituent(s), Z is an optionally halogenated C1-6 alkyl group, Y is a methylene group optionally having substituent(s), m and n are each an integer of 0 to 5, m+n is an integer of 2 to 5, and is a single bond or a double bond, or a salt thereof. The compound of the present invention has a superior tachykinin receptor antagonistic action, particularly an SP receptor antagonistic action, and is useful as a pharmaceutical agent, for example, a tachykinin receptor antagonist, an agent for the prophylaxis or treatment of an abnormality of lower urinary tract functions, a digestive organ disease or a central nerve disease, and the like.

  本发明涉及一种由式表示的化合物 其中环 A 是可选进一步具有取代基的含氮杂环，环 B 和环 C 各是可选具有取代基的芳香环，R1 是氢原子、可选具有取代基的烃基、酰基或可选具有取代基的杂环基团，Z 是可选被卤化的 C1-6 烷基，R2 是可选被卤化的 C1-6 烷基，R3 是可选被卤化的 C1-6 烷基，R4 是可选被卤化的 C1-6 烷基、Z 是可选的卤代 C1-6 烷基，Y 是可选的亚甲基，m 和 n 分别是 0 至 5 的整数，m+n 是 2 至 5 的整数，并且是单键或双键，或其盐。本发明的化合物具有优异的速激肽受体拮抗作用，特别是 SP 受体拮抗作用，可用作药物制剂，例如速激肽受体拮抗剂，预防或治疗下尿路功能异常、消化器官疾病或中枢神经疾病等的药物。
• Novel 3-phenylpiperidine-4-carboxamides as highly potent and orally long-acting neurokinin-1 receptor antagonists with reduced CYP3A induction
  作者：Junya Shirai、Hideyuki Sugiyama、Shinji Morimoto、Hironobu Maezaki、Yasuharu Yamamoto、Satoshi Okanishi、Izumi Kamo、Shiho Matsumoto、Keiko Ishigami、Nobuhiro Inatomi、Akio Imanishi、Makiko Kawamoto、Naoki Tarui、Tadatoshi Hashimoto、Yoshinori Ikeura

  DOI：10.1016/j.bmc.2011.11.048

  日期：2012.1

  The synthesis and biological evaluation of a series of novel 3-phenylpiperidine-4-carboxamide derivatives are described. These compounds are generated by hybridization of the substructures from two types of tachykinin NK1 receptor antagonists. Compound 42 showed high metabolic stability and excellent efficacy in the guinea-pig GR-73637-induced locomotive activity assay at 1 and 24 h after oral administration. It also exhibited good pharmacokinetic profiles in four animal species, and a low potential in a pregnane X receptor induction assay. (C) 2011 Elsevier Ltd. All rights reserved.
• EP1705176
  申请人：——

  公开号：——

  公开（公告）日：——